Pure Global
NCT06402097

TRIP-patch vs Duplex

'Transdermal Rigidity Assessment Via Ischemia of the Penis (TRIP). A New Sensor-driven Device to Measure Maximal Rigidity.'
St. Antonius Hospital·ClinicalTrials.govCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Erectile Dysfunction
Study type
Observational
Sponsor & location
Primary sponsor
St. Antonius Hospital
Location
Nieuwegein, Netherlands
Timeline & enrollment
Phase
N/A
Start date
Jun 05, 2020
End date
Sep 25, 2020
Enrollment
20 participants
Primary outcome

change in sensor-readings

Summary

To measure saturation and desaturation of the cavernosal tissue with a cutaneous placed
 penile sensor, before and during full rigidity. To validate discriminating sensor-readings
 between flaccid state and full rigidity of the penis

ICD-10 classifications
Orgasmic dysfunctionOther disorders of penisOther specified disorders of penisSexual dysfunction, not caused by organic disorder or diseaseTesticular dysfunction
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06402097
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06402097 through Pure Global AI's free database. This phase not specified trial is sponsored by St. Antonius Hospital and is currently Completed. The study focuses on Erectile Dysfunction. Target enrollment is 20 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.